相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel germline JAK2 mutation in familial myeloproliferative neoplasms
Elisa Rumi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Impact of isolated germline JAK2V617I mutation on human hematopoiesis
Adam J. Mead et al.
BLOOD (2013)
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms
Elisa Rumi et al.
BLOOD (2013)
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
J. Nangalia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms
Damla Olcaydu et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Deep sequencing reveals double mutations in cis of MPL exon 10 in myelloproliferative neoplasm's
Daniela Pietra et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms
Franz X. Schaub et al.
BLOOD (2010)
Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
Charlotte M. Niemeyer et al.
NATURE GENETICS (2010)
Genetic origins and clinical phenotype of familial and acquired erythrocytosis and thrombocytosis
Melanie J. Percy et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis
Luca Malcovati et al.
BLOOD (2009)
Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders
Daniela Pietra et al.
BLOOD (2008)
Familial chronic myeloproliferative disorders: Clinical phenotype and evidence of disease anticipation
Elisa Rumi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders
Elisa Rumi et al.
CANCER (2006)
Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders
Christine Bellanne-Chantelot et al.
BLOOD (2006)
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin
F Ding et al.
BLOOD (2004)
分享论文
